SEROTYPE 2 DENGUE Â Â
Disclaimer: No Copyright infringement intended.
Context
- The Health Ministry has flagged the emerging challenge in 11 States across India of serotype 2 dengue, which it said is associated with “more cases and more complications” than other forms of the disease.
About Dengue
- It is a tropical disease that occurs in the countries around the Equator.
- Aedes aegypti transmits dengue virus.
- Aedes eggs can remain dormant for more than a year.
- The virus responsible for causing dengue, is called dengue virus (DENV).
- There are four DENV serotypes (DENV-1, DENV-2, DENV-3 and DENV-4), meaning that it is possible to be infected four times.
Reasons behind spread of Dengue
- Poor Urbanization
- Poor town planning
- Improper sanitation
- Dengue cases are often under-reported due to political reasons
- Low number of skilled manpower
- Due to this deficiency of manpower, active surveillance is not being done in India, according to National Vector Borne Disease Control Program.
- There is a lack of coordination between the local bodies and health departments in the delivery of public health measures.
- Medicine practitioners often argue that a proper double blind, randomized, placebo-controlled trial cannot be conducted as it involves huge money and manpower.
Holistic management of Dengue
- These mosquitoes bite during the daytime, so keeping the windows shut in the day hours is also useful.
- Preventing water stagnation
- Spreading chemicals in periodic cycles to kill the larvae.
- Singapore uses successful model of mapping and analyzing data on dengue, using Geographical Information System (GIS). This involves mapping the streets with dengue cases for vector densities.
- Fluid management is the cornerstone in the management of severe diseases like dengue hemorrhagic fever and dengue shock syndrome.
- WHO recommends fresh whole blood or packed cell transfusion in the event of bleeding.
- Increase the number of personnel in the healthcare sector.
- Delhi government Mohalla Clinic is a successful model to engage local community in effective management of Dengue.
Vaccine
- As of 2021, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia.